Pushing the Boundaries of Knowledge in Alpha-1 Antitrypsin Deficiency.
Cutting-edge preclinical and translational developments with potential to redefine AATD management and move toward curative approaches are highlighted, highlighting cutting-edge preclinical and translational developments with potential to redefine AATD management.
J. M. Hernández-Pérez, Silvia Castillo-Corullón, I. Ferrarotti et al.
· Archivos de Bronconeumologia · 0 citations